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Therehasbeeni ncreasing interest in developing robotics and information technologies for assisting in physical rehabilitation after neurologic injuries and disease. 1, 2 Such technologies could potentially allow more engaging forms of therapy to be accessed with less supervision, better quantify therapy and its impact, and improve outcomes. Whereas the first two capabilities are being achieved at least to some extent, the third has arguably not been achieved. In its current forms for the upper limb, robot-assisted therapy has typically been shown to be comparably effective to conventional therapy when the dose of the conventional therapy is matched. 3, 4 For example, the recent multisite randomized controlled trial of Massachusetts Institute of Technology-MANUS in chronic stroke found comparable reductions in upper limb impairment after robot or dose-matched therapist-assisted treatment. 5 The forms of robot-assisted therapy tested so far are only few among a large set of possibilities. The tasks practiced, the nature of the physical interaction with the robot, and the elements of feedback provided by the robot to the patient can all be varied in multitudinous ways, some yet unimagined. Thus, the field of robot-assisted therapy might be characterized as currently being at a stage in which a search for optimal parameters may lead to achievement of the third capabilityVthat of machine-assisted therapy that is more effective than conventional therapy.
In the randomized controlled study reported here, a form of robot therapy was tested, with motivations of two primary considerations. First, the authors desired to have patients practice arm movement in three dimensions against gravity in the context of simulated functional tasks that required use of the hand. Many activities of daily living require three-dimensional (3D) movement against gravity and use of the hand, and the authors hypothesized that training such movements in the context of functional tasks rather than supported arm movements or single-joint arm movements that simply required target tracking would increase the overall benefits of training because of the principle of specificity of motor training. The authors therefore built a robotic device called Pneu-WREX that allows naturalistic motion of the arm in three dimensions (Figure 1 ). 6Y8 Pneu-WREX is a pneumatically actuated version of a nonactuated arm support T-WREX, 9 which was based on the innovative mobile arm support called WREX developed by Rahman et al. 10 for children with arm impairment. The authors previously tested T-WREX with chronic stroke subjects and found that training with this nonrobotic exoskeleton indeed significantly reduced arm motor impairment compared with conventional tabletop training. 11 However, in the authors' previous study with T-WREX, patients were not assisted robotically in completing movements. Thus, second, the authors desired to test a form of robot therapy that ensured that the patients completed 3D movements while still requiring the patient to exert substantial effort to complete those movements. The authors' premise was that helping patients finish target movements would deliver enhanced somatosensory stimulation and complete and accurate proprioceptive signals that assist in neural reorganization, perhaps by activating Hebbian-like plasticity processes that depend on afferent input that is correlated with motor output. However, this premise was conditioned by the FIGURE 1 Pneu-WREX is a 4 degree-of-freedom pneumatically actuated upper limb orthosis for robot-aided authors' and other's previous findings that assisting in movements with a robot can, on the other hand, induce a slacking response by the patient, measured as a reduction in force output 7 or energy consumption, 12 or a decrease in learning that is apparent in motor learning studies of healthy subjects. 13Y16 Thus, it was considered that the benefits of increased somatosensory stimulation generated by robot-assisted movement may be offset by the negative consequences that a reduction in patient effort 17 or learning might bring for recovery, if care is not taken to prevent this reduction. Therefore, a controller for Pneu-WREX was designed that learns a model of the patient's ability to try to provide a subject-specific, appropriate level of assistance. 7 A standard sliding adaptive controller was originally used to learn the position-dependent forces required to assist people in completing tracking games in 3D against gravity, representing those forces using radial-basis functions. However, the authors found that people with and without stroke subconsciously allowed the adaptive controller to Btake over[ the forceful part of the tracking task, relaxing their own force output. To counter this slacking, a forgetting term was added to the adaptive controller that continuously sought to reduce the force output of the robot as well; essentially, the authors made the robot slack as well. Introduction of this term caused individuals to experience small amounts of tracking error, which were enough to cause them to substantially increase their effort for the task. 7 Thus, the controller assisted them in achieving the desired movements while preventing slacking.
In this study, the authors tested the hypothesis that use of this antislacking, assist-as-needed controller for 3D movement training would improve recovery beyond the results possible with conventional tabletop training for a group of people with chronic stroke. Portions of this work were reported previously in conference paper format. 18 
METHODS Subjects
A total of 27 adult stroke survivors were recruited through local hospitals and stroke support groups in Orange County, CA. All participants had a single ischemic or hemorrhagic stroke and were at least 3 mos post-stroke at the time of their enrollment into the program. All participants demonstrated moderate to severe weakness of their affected upper limbs, defined by the upper limb Fugl-Meyer (FM) Motor Scale (score of 10Y35 of 66). 19 Exclusion criteria included significant pain, instability or subluxation of the af-fected shoulder, severe elbow or wrist contractures, concurrent severe medical problems, cognitive dysfunction to the extent that would interfere with therapy participation, visual deficits, severe neglect or apraxia, and current enrollment in ongoing upper limb therapy. All subjects provided written consent, and all procedures were approved by the institutional review board of the University of California in Irvine.
Device: Pneu-WREX
The robotic device used for this study is called Pneu-WREX. It is a 4 degree-of-freedom robot based on a passive arm support called WREX. Pneu-WREX is a lightweight exoskeleton that allows a wide range of motion of the arm in a 3D space by incorporating pneumatic actuators to generate active forces. The actuated degrees of freedom are elbow flexion/ extension, shoulder horizontal abduction/adduction, shoulder flexion/extension, and shoulder forwardbackward translation. The device incorporates a passive weight support mechanism similar to the one used in WREX, the design of which constrains the forearm to remain parallel to the ground as it moves through 3D space. As stated above, it relies on an adaptive controller to learn the dynamics of the patient's arm, ability, and effort at the same time and also contains a forgetting term that reduces patient slacking. Therefore, the device can provide assistance as needed for a patient to actively participate and be able to complete 3D tasks. Hand training through grasp and release is incorporated through a grip sensor that measures the pressure of a water-filled cylinder bladder that the user holds, to detect even trace finger movement.
Position sensors located at the joints of the Pneu-WREX exoskeleton allow it to be used as an input device to measure arm movement of the affected limb. A software package called Vu Therapy designed at the University of California Irvine allowed for the interface of the robotic arm and the simulated environment. The games were designed to be functionally oriented, with the patient completing familiar, taskoriented movements. Tasks included grocery shopping (i.e., grasping objects off of a shelf and dropping them into a grocery cart), cleaning a window, playing basketball, and driving a car. Auditory and visual feedback and a game score were provided throughout game play to maintain the patient's attention and interest.
Assignment and Intervention
This study compared the change in arm movement ability of subjects who participated in Pneu-WREX training with that of control subjects who exercised for the same duration without the device and received similar amounts of supervision from a therapist. Subjects participated in 24 one-hour treatment sessions, approximately three times per week for 8 to 9 wks, except one subject in the Pneu-WREX group, who experienced 21 sessions because of a temporary medical problem unrelated to the study. All training sessions were supervised by a physical therapist at all times. Each treatment session began with the therapist performing passive range of motion exercise of the arm and obtaining blood pressure and pain ratings. Subjects also recorded blood pressure and pain ratings after each treatment session.
Groups of four to five subjects were enrolled at a time. To ensure a match in age and impairment severity between groups, subjects were first stratified by age (G 60, 61Y74, and 975 yrs) and FM score (9Y17, 18Y27, and 28Y66). Subjects in these groups were then randomly assigned to the Pneu-WREX or control groups by a computerized randomization algorithm. The treating therapists and subjects were blinded to group assignment until each subject was consented and enrolled in the study.
Subjects assigned to the control group participated in conventional exercises, which were developed previously by Sarah Housman, MS OTR/L, at the Rehabilitation Institute of Chicago and had been tested in a study of the T-WREX device. 11 These exercises were typical of conventional home programs and consisted of three sections, including self range of motion stretches, active range of motion strengthening exercises, and a list of activity of daily living tasks throughout the hemiparetic upper limb. During self range of motion stretches, participants clasped their hands or arms together and used the strength of the less affected arm to move the affected arm through the available range of motion at each joint. During active range of motion exercises, the hemiparetic arm was supported against gravity by a tabletop and a towel was placed under the arm to decrease friction as subjects completed specified movements unilaterally. All sessions were supervised by a physical therapist who provided cueing or assistance as needed.
Individuals in the robot group completed approximately three to five repetitions of five therapy games each session using Pneu-WREX. Subjects followed the preset movements on the computer screen, which were indicated by a cursor that looked like a hand, in the simulated environment. These movements involved reaching, grasping, grasp release, and horizontal movement. Pneu-WREX provided assistance as needed for participants to complete the arm movements. Grasp force thresholds required to manipulate virtual objects were adjusted by the supervising therapist according to subject ability; some subjects had no discernible hand function and were unable to use the gripper. All activities on Pneu-WREX were also supervised by the same physical therapist who again provided verbal cueing as needed. The games incorporated auditory feedback to signal successful completion of the task (e.g., placing an item in a shopping cart.), and the screen showed the number of successful movements completed or the time of completion for each game.
To minimize the possibility of a placebo-like benefit that could arise in the robot-trained group because of expectations associated with using a high-tech device, subjects in the control group crossed over to the robot treatment group 30 mins weekly; the intent was to give the control group limited exposure to the robot as well to offset any Bhigh-tech[ placebo effect. Likewise, to minimize the possibility of a bias that could arise for the control group because they trained unassisted movements close to the ones used in the clinical evaluations, subjects in the robot group crossed over to the conventional training group 30 mins per week; again, this gave the robot group limited exposure to unassisted, functional training as well. Thus, each group overall experienced a blend of 84% of their primary therapy, and 16% of the other, as the 30 mins of crossover were included in the 3 hrs per week of training.
Assessment Procedures
Subjects were assessed twice before the initiation of the treatment sessions, at 2 wks before and 1 wk before the study. Subjects were also assessed after the completion of the 24 treatment sessions and at a 3-mo follow-up assessment. A single blinded rater performed all of the clinical assessments during all testing sessions. The primary outcome measure was the arm motor section of the FM Scale, which assesses arm movement ability outside of synergy patterns. 20 Other outcome measures included the Rancho Functional Test for the Hemiplegic/Paretic Upper Extremity, 21 which tests the ability of subjects to complete functional activities of graded difficulty, assigning them a level based on the most difficult task they can perform; the Motor Activity Log, 22 a 5-point self-report of how much and how well the subject is using the arm for 30 daily tasks; the Box and Blocks Test, 23 which tests how many blocks the subject can grasp and transport in 1 min; grip strength, measured with a Jamar Hand Dynamometer; and the Nottingham Sensory Assessment (NSA). 24 The NSA assesses tactile sensation (light touch and pinprick) and kinesthesia at the shoulder, elbow, wrist, and hand and stereognosis using a pen, comb, and sponge. Each item of the NSA was graded from 0 (worst function) to 2 (preserved sensation), except for kinesthesia, which was scored from 0 to 3 points (worst and best function, respectively). The total possible NSA score was 34.
Statistical Analysis
Because it was hypothesized that participants would improve their movement ability with robotic or conventional training, pretreatment to posttreatment changes were assessed using one-sided paired t tests, comparing the average of the two baseline assessments to the assessments after the training program and at 3-mo follow-up. To test the study hypothesis that robotic training with the assist-asneeded controller improved recovery more than conventional tabletop training, the motor gains between groups were compared using one-sided t tests. The authors did not correct for multiple comparisons. 25 
RESULTS
Assist-as-needed, 3D arm/hand robotic movement training was compared with conventional tabletop upper limb exercises. A total of 52 subjects were screened for the study, and 27 subjects were enrolled, 13 in the robot group and 14 in the control group. Follow-up data were not available for one subject who was enrolled in the control group because the subject moved out of the area; thus, this subject was removed from the analysis. The baseline enrollment characteristics are shown in Table 1 . The robot and control groups were well matched in age, time since stroke, and side of hemiparesis, but there were more men in the control group. There were no safety concerns related to use of the robot and no adverse events attributable to the robotassisted therapy.
The clinical motor scores at each assessment are shown in Table 2 . The scores did not change significantly from baseline evaluation 1 to baseline evaluation 2, except for the FM score for the robot group. After 24 training sessions, the robot group significantly improved the FM score, the NSA score, the Motor Activity Log quality of movement score, grip strength, and Box and Blocks score. Only the NSA score remained significantly improved at the 3-mo follow-up for the robot group, although there was a trend in greater improvement in FM score for the robot group (P = 0.06). The control group improved the FM score and Rancho level after 24 training sessions; these improvements did not persist at the 3-mo follow-up, although the control group also exhibited improved sensory scores at the 3-mo follow-up.
The changes in clinical scores are compared between groups in Table 3 and Figure 2 . There was a trend for the robot group to have larger improvements in FM score and Box and Blocks score after 24 training sessions (P = 0.07 and P = 0.06, respectively). There was also a trend for the robot group to have larger improvements in FM score and Nottingham Sensory score at the 3-mo follow-up that (P = 0.06).
When asked which training program they preferred, individuals who had experienced the robot program more often picked the robot program ( Figure 3 ). They rated it as less boring and as the program they were more likely to complete at home. Individuals who participated in the control group still preferred the robot therapy based on their limited experience of it, but not as strongly as those who participated in the robot group.
DISCUSSION
This study suggests that robot-assisted training can safely improve sensory motor recovery for individuals with a chronic, severe to moderate impairment, although it should be noted that the improvements measured were small. There was also a trend toward greater improvements with robot-assisted training compared with conventional tabletop training. This trend, along with the improved repeatability, quantifiability, and engagingness of the therapy delivered, and the possibility for increased dosage through more semiautonomous training are possible benefits of robot-assisted therapy. The authors first discuss what aspects of the robot-assisted therapy tested here may have contributed to the observed results then discuss study limitations and key directions for future research. Robotic therapy devices provide an engaging way for people with stroke to practice meaningful tasks, and they provide somatosensory stimulation beyond what a patient could normally achieve during unassisted practice. These features may assist in brain reorganization of motor networks. 26 On the other hand, by virtue of physically assisting in movement, robotic therapy devices may have the unintended consequence of causing patients to di-minish their own effort in achieving a desired task. The human motor system can be viewed in part as an Beffort optimizer[ or Bslacker[: studies have found that helping people complete movement tasks with robotic devices causes the motor system to systematically reduce its output 7, 12, 27, 28 and can reduce normal motor learning. 13Y16 If the magnitude of motor output is important for improving motor performance, as it is in strength training 29 and as implied by a study of robotic rehabilitation therapy that found little benefit to patient-passive therapy, 17 then the implication is that care must be taken in robot-assisted therapy to not Boverassist[ the patient. In other words, assistance may have both positive effects (increased somatosensory stimulation, complete and accurate proprioceptive signals, better engagement, better ability to do tasks and thus receive positive feedback about efforts) and negative effects (decreased patient effort and reduced need to Bsolve[ the problem of relearning arm control). A key goal for robotic therapy device research is to increase the positive effects while decreasing the negative ones.
In this study, the robot continuously estimated the assistance that the patient needed to achieve the current task and then provided slightly less assistance than the estimated amount. The authors had previously found that this approach induces subjects with stroke to exert substantially more effort than when the estimated amount of assistance is provided. 7 The benefits of robot-assisted therapy found in this study may thus have been caused by, in part, the way the robot encouraged subjects to exert more effort.
The benefits may also have arisen in part because of the fact that the robot allowed 3D movements that incorporate hand grip and release, rather than just planar or single-joint movements. The authors previously found that movement training with a nonactuated exoskeleton similar in geometry to the actuated robot used in this study, which allowed similar 3D movements and hand grip and release, also produced better results than conventional tabletop training. 11 Although it is difficult to compare between studies because of the heterogeneity of individuals with stroke, the benefits with the nonactuated exoskeleton measured previously were similar to the benefits with the actuated exoskeleton used here. This suggests that the 3D nature of therapy rather than the particular form of assistance provided may have been the determinant of recovery, although it should be noted that both exoskeletons demanded significant effort from their users. Consistent with this interpretation, one of the few studies to find that robot-assisted arm therapy produced better outcomes than a matched dose of conventional therapy used a robot that allowed 3D movement of the hand. 30 It may be that training 3D movements with use of the hand is beneficial because the arm is normally used in 3D in conjunction with the hand, including in many clinical evaluations such as the ones used here.
Limitations and Future Directions
This study had several limitations. These are discussed here and are used to illustrate and discuss more general limitations in the field of robotic therapy.
One limitation of the study is that there were multiple differences between the two treatment arms, and thus, no single variable was explicitly tested. For example, antislacking robotic therapy was not directly compared with non-antislacking robotic therapy. Thus, it is impossible to determine definitively if the antislacking component of the therapy was in fact the beneficial component. Likewise, the study did not compare 3D with non-3D therapy, and thus, it is impossible to determine definitely that 3D therapy was the cause of the observed trend (or that inclusion of the hand grip and release in training was better). Future research should make these isolated comparisons to increase insight into the attributes of robotic therapy that are most important to achieving maximum behavioral gains. However, the authors point out that there are a huge number of possible isolated comparisons to make when considering the elements of robotassisted therapy, including comparisons of the tasks practiced, the nature of the physical interaction with the robot, and the elements of feedback provided by the robot to the patient, as well as yet unimagined variations. Making isolated comparisons is time consuming and expensive. In the authors' view, one solution would be the development of short-term assays that accurately assess the sensitivity of longterm recovery to individual changes in robot-assisted therapy paradigms. The authors envision, specifically, a behavioral or brain-imaging probe (or combination of both) that can be made during or shortly after a single session of therapy and that gives insight into whether the parameters used in that single session of therapy were beneficial in provoking learning (e.g., Koski et al. 31 ). Determining how to assay shortterm precursors of long-term plasticity and learning is an important goal for the field.
Another limitation of this study is that the comparative benefits of the robot therapy did not cross the 0.05 level of significance routinely used in statistical testing, even when using one-sided tests and without correcting for multiple comparisons. The use of multiple t tests (i.e., unrestricted least significant difference procedure) has been argued to improve the consistency of multiple comparisons. 25 The fact that significance levels only bordered on 0.05 requires accepting a 6% chance of a type I error rather than a 5% chance of type I error, which is perhaps reasonable given that the historical selection of the 5% level was somewhat arbitrary. 32 The lack of significance may have been caused by the relatively small sample size. The field of robot-assisted therapy and rehabilitation science, in general, often suffers from low power, mainly because of difficulties in recruiting subjects and the substantial resources needed to deliver months of focused therapy. In addition, large levels of interpatient variability reduce the power to detect a difference when one is truly present. Entry criteria or patient stratification might best be achieved by including some biologic measures of neural injury or function, 33 increasing study power.
Another limitation of the study, which again is a limitation of the field of stroke motor rehabilitation as a whole, 5 is that the observed benefits of the training were small and could be considered as having limited clinical significance. The primary benefits of robot-assisted training measured here were a small reduction in impairment as measured by the primary outcome measure, the FM score, which focuses on motor ability, and the NSA, which measures tactile and proprioceptive perception. The functional scales that were used, the Rancho Test and the Motor Activity Log, did not detect much benefit of either training type. Conventional tabletop training showed even less benefit, and this may have been because relatively few movements are typically performed in this type of training, as was quantified previously in a study of conventional upper limb treatment approaches. 34 These results are consistent with the previous study of T-WREX that also used this type of control training and found only a small improvement due to the control training (2.2 FM points), which again faded at long-term follow-up. In addition, volunteers who participated in this study were, on average, quite impaired, and thus, they may not have had the neural resources needed to substantially improve their arm and hand function because of the anatomy of stroke-induced neural injury. Making a larger impact with robot-assisted therapy may depend, in part, on better identifying the patients who can most benefit from the therapy, using brain imaging 33, 35, 36 or quantitative records of the amount of therapy people have previously engaged in. Ultimately, the hope for greater impact lies with combining robotic therapy and biologic, pharmaceutical, or electrical stimulationYbased approaches to enhancing plasticity and regeneration (see, e.g., Courtine et al. 37 ). Such combination therapies are already benefitting from robotic delivery of therapy because the robot helps control the type and amount of training delivered while also quantifying the behavioral outcomes of that therapy.
